Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism. - Shi J; Xiao J; Wang X; Jung SM; Bleske BE; Markowitz JS; Patrick KS; Zhu HJ (Clinical pharmacology and therapeutics, 2022)